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Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host
cells infiltrating tumour spheroids
K.M. Wilson & E.M. Lord
Cancer Center and Department ofMicrobiology and Immunology, University ofRochester, Rochester, NY 14642, USA.
Summary The development of a serum-free, low-protein culture medium has allowed the detection of
tumour-specific cytolytic cells in EMT6 immunized mice bearing EMT6 multicellular tumour spheroids.
Spheroid associated (SAC) and peritoneal (PC) effector cells were specific to EMT6 as the target cell, not
killing line 1, P815 or RIF-1. The natural killer (NK) cell sensitive target YAC-1 was also not lysed by SAC
or PC, indicating undetectable levels of NK cells present within infiltrated spheroids. In contrast, high levels
of cytolytic activity were present in SAC, PC and spleen cells against WEHI-164, a line sensitive to natural
cytotoxic (NC) and macrophage mediated killing. The EMT6 specific acitivity was mediated by Thyl+, Lyt2+
cells. The anti-WEHI-164 effector cell population was Thyl-, Lyt2-. The WEHI-164 killer cells were present
in SAC and PC from unimmunized mice while the EMT6 specific effector cells were not. After separation of
SAC and PC by size using centrifugal elutriation, anti-EMT6 activity was present only in the lymphocyte
fraction while anti-WEHI-164 activity was enriched in the macrophage fraction.
The multicellular tumour spheroid (MTS) (Sutherland et al., et al., 1983). Except for a few animal studies (Ferry et al.,
1971) is a useful tumour model because it has many of the 1984), NK activity within tumours has not been observed
three dimensional characteristics of a solid tumour (Eremin et al., 1981; Totterman et al., 1980). NC activity is
(Sutherland & Durand, 1984; MacDonald & Sordat, 1980). against some different targets such as the WEHI-164
However, unlike solid tumours, MTS are easily dissociated sarcoma and is mediated by Thyl- cells (Lattime et al., 1982;
into single cells by a mild trypsinization without loss of cell 1983). Recently it has been shown that NC activity may be
viability or function. We have used this model previously to mediated by tumour necrosis factor (TNF) (Ortaldo et al.,
demonstrate anti-EMT6 cytolytic activity by spheroid 1986). TNF has also been implicated in the lysis of WEHI-
associated cells (SAC) from immunized spheroid bearing 164 by mouse resident and peptone-induced peritoneal cells
mice (Lord, 1980; Lord & Burkhardt, 1984). This anti- and human fresh, cultured and LPS stimulated monocytes
EMT6 activity was higher than that of peritoneal (PC) and (Colotta et al., 1986; Austgulen et al., 1986; Chen et al.,
spleen cells, showing the importance of studying in situ host 1985; Kildahl-Anderson et al., 1986; McKinnon, 1986;
cells (Lord & Burkhardt, 1984). However, since the immun- McKinnon et al., 1986). Since macrophages are present in
izing EMT6 tumour cells and tumour spheroids were grown high numbers in EMT6 solid tumours and MTS (Lord &
in foetal calf serum containing media, it was unclear whether Keng, 1984; Lord & Burkhardt, 1984), the non-specific
the observed cytotoxicity represented specific anti-tumour cytotoxicity observed in the EMT6 system against WEHI-
immunity. 164 could be mediated by macrophages via TNF.
Cytolytic effector cells can be generated in vitro as the The objective of this research was to demonstrate specific
result of culture with foetal bovine serum (FBS), or in vivo anti-tumour cytolytic activity by in situ host cells in the
following injection with FBS alone without specific antigen absence of xenogeneic serum. We examined the specificity of
(Golstein et al., 1978). The activation of these cytolytic cells anti-tumour cytolytic activity and characterized the effector
has been attributed to both the antigenic and mitogenic cells responsible for anti-EMT6 and anti-WEHI-164 activity.
nature of xenogeneic serum. Since FBS components
adsorbed or bound onto the surface of cells are not readily
removed by washing (Golstein et al., 1978; Kubota, 1984), Materials and methods
immunization with tumour cells grown in vitro in serum
containing media could potentially elicit non-specific effector Mice
cells. We have demonstrated the generation of effector cell B
populations that lyse not only EMT6 but also a number of ALab/cBy fal wer,E purchsed from teJkson
other tumour cell targets by inoculation of animals with Laboratories, Bar Harbor, ME and used at 1-20 weeks of
EMT6 cells cultured in FBS supplemented media and/or age
culture of spleen cells from tumour bearing mice in FBS .. _ . . . ~~~~~Tissue Cutture Medium supplemented media (Reynolds et al., manuscript in
preparation). Development of a serum-free, low-protein Complete MAT/P (CMP), a serum-free, low-protein medium
medium (MAT/P) (Taupier et al., 1985; 1986) in our (Taupier et al., 1985; 1986), was used for all experiments.
laboratory for the culture of tumour cells and multicellular Proteins used were insulin (0.005mgml-1) and transferrin
tumour spheroids has allowed us to demonstrate specific (0.005mgml -1). All media were stored and used under
anti-tumour immunity. yellow light. Tumour cells lines were adapted to serum-free
In situ antigen specific Thyl+, Lyt2+ cytotoxic T lympho- medium by first reducing FBS concentration from 10% to
cytes (CTL) can be active in anti-tumour responses 2% in MAT/P before using serum-free conditions.
(DeLustro & Haskill, 1978). Natural killer (NK) cells and
natural cytotoxic (NC) cells have been shown to have Tumour system
spontaneous cytolytic activity against a wide variety of ET sammaysroawihaoesotnosyi
tumours (Lattime et at., 1982). NK cells can be detected in a ET Sammaysroawshaoesotnosyi
4h chromium release assay and kill NK-sensitive in vitro aBL/ os n a usqetyaatdfrtsu
grown tumour lines such as the YAC-1 lymphoma (Lattime culture (Rockwell et at., 1972). The subline designated
EMT6/Ro (Rochester) was used for the experiments reported
____________________________________________ here. All cell lines were tested periodically for mycoplasmal
Correspondence: K.M. Wilson. contamination by Mycotrim (Hanna Media Inc., Berkeley,
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mouse viruses as tested by the MAP test (M.A. Bioproducts, Antibody plus complement treatment
Rockville, MD). Treatment with cytotoxic monoclonal antibodies (ascites)
YAC-1, a lymphoma, was induced by Moloney virus in an plus complement was used to remove cell subpopulations
A/Sn mouse (Cikes et al., 1973). WEHI-164, a fibrosarcoma, prior to chromium release assay. Anti-Thyl.2 was produced
was induced by methylcholanthrene in a BALB/c mouse by Ho13.4 (Marshak-Rothstein et al., 1979), and anti-Lyt2.2
(Rollinghoff & Warner, 1973). RIF-I (Twentyman et al., by H023- (Raulet et al., 19 79), and anti-Lyt2re
1980), a fibrosarcoma, was induced by radiation in a C3H by H02.2 (Raulet et al., 1980). Cells at I x 107ml-1 were
mouse P815 (Dunn & Potter, 1957), a mastocytoma, was suspended in the appropriate dilution (determined by
induced by methylcholanthrene in a DBA/2 mouse. Line-i titration) of antibody and placed on ice for 30min. The cells indcedby ethlchlanhree i a BA/ mose.Lin-I were then centrifuged, resuspended in the appropriate (Yuhas et al., 1974), a lung carcinoma, arose spontaneously gilution etrined py t cpp opriat
in a BALB/c mouse. dilution (determined by titration) of rabbit complement (CedarLane), and incubated at 37°C for 30min. The cells
Multicellular tumour spheroids were then washed, resuspended in medium and counted.
Multicellular tumour spheroids (MTS) were grown in vitro as Centrifugal elutriation
previously described (Lord et al., 1979). Spheroids were A centrifugal elutriation procedure was utilized to separate
initiated in vitro by placing 5 x 105 EMT6 tumour cells into cebpopulat oftraCion d PC (Lord t
K eparate
100mm non-tissue culture petri dishes (Labtek). After 45 subpopulations of SAC and PC (Lord & Keng, 1984). 100 m no-tisue ultre ptridishs (abte). fter4-5 Single cell suspensions from implanted spheroids were elutri- days the small spheroids were transferred to spinner flasks adngme pell s is ned spheroidseru plutri-
containing 150ml MAT/P and medium replenished daily. ated in media containing 10% newborn calf serum at 4°C. MTScontaining 0 mlMATiPameter, o edium r replenihees
d . The flow rate was raised from 25 to 41 mlmin-I while the MTS of 600-800pm diameter, obtained after - 2 weeks of rotor speed was decreased in increments from 4000 to
growth, were used for all experiments. 0r.p.m. and fractions collected at each interval. Lymphocyte
Spheroid implantation and recovery fractions had a mean cell volume of 300pm while macro-
phage fractions contained cells ranging from 700-1500pm.
MTS (60/mouse) were implanted into the peritoneal cavity
using an 18-gauge needle as previously reported (Lord et al.,
1979). After 4-6 days spheroids were recovered by flushing Results
the peritoneal cavity with a balanced salt solution (BSS)
containing sodium heparin (Gibco) at 5 Uml-1. The Cytolytic activity in the absence offoetal bovine serum
spheroids were separated from the peritoneal cells by unit
gravity sedimentation. Spleens from the same animals were We have previously determined that spheroid associated cells
gently teased into single cell suspensions and washed with (SAC) recovered from mice immunized with irradiated
BSS. Spheroids were washed three times with BSS and EMT6 cells and injected with EMT6 multicellular tumour
dissociated into single cell suspensions with 0.05% trypsin spheroids had cytolytic activity against radiolabelled EMT6
for two 0inm periods at 37sC. Spheroid associated cells cells (Lord and Burkhardt, 1984). It was a concern that this
(SAC) were washed three times with cold BSS to remove activity might be the result of bovine serum components
trypsin. adhering to the immunizing cells since xenogeneic serum has
been show to elicit cytotoxic cells (Golstein et al., 1978;
Reynolds et al., manuscript in preparation). To overcome
Immunization this potential problem, a serum-free, low-protein defined
Mice were immunized 10-14 days prior to spheroid implan- media (MAT/P) was used for growth of immunizing cells
tation with an i.p. injection of 5x 106 washed, irradiated and spheroids, and in the chromium release assay. The
(50Gy) EMT6 cells from in vivo monolayer culture. added proteins, insulin and transferrin, do not interfere with
generation of specific immunity (Reynolds et al., manuscript
Cytotoxicity assay in preparation). Growth kinetics (size, plating efficiency and
number clonogenic cells per spheroid) of tumour spheroids
An 18 h chromium release assay was used to measure implanted in immunized and unprimed mice using serum-free
cytolytic ability of SAC, PC and spleen cells as previously conditions were similar to those previously published using
described (Lord & Burkhardt, 1984a; Wilson & Lord, 1986). FBS containing media (Lord & Burkhardt 1984; data not
Two-fold dilutions of effector cells were prepared in 96 well shown).
flat bottomed plates. Ten thousand 5'Cr labelled exponen- An 18 h chromium release assay was performed using
tially growing EMT6 target cells were added to each spheroid associated cells (SAC), peritoneal cells (PC) and
well. The plates were incubated 18 h at 37°C, then 0.1 ml spleen cells from immunized spheroid bearing mice as
supernatant removed and counted for radioactivity. Spon- effectors, and monolayer EMT6 as radiolabelled targets.
taneous release was measured by incubating targets with SAC were found to possess the greatest cytolytic ability
media alone. Complete release was determined by adding a against EMT6 (Figure 1). The PC also demonstrated cyto-
1:20 dilution of ZAP-isoton (Coulter Electronics) to targets. lytic activity although to a slightly lesser extent. Spleen cells
Four hour assays were identical, with the exception that V from these mice had little or no cytolytic ability. Thus the
bottom plates were used and spun at 200r.p.m. for 2min at host cells infiltrating tumour spheroids were cytolytic in the
room temperature after addition of cells. Percent specific absence of FBS, and had greater activity than those cells of
lysis (%SL) was calculated from release of radiolabel from the periphery.
target cells, according to the following formula:
Specificity ofin situ andperitoneal effector cells
SL=(experimental mean-spontaneous mean) Lysis of EMT6 target cells is observed only in animals
SL= ~~~~~~~~~~~immunized with EMT6: no anti-EMT6 activity was detected
(competeean-sontaeous ean)from SAC when mice were immunized with a different
tumour (Lord & Burkhardt, 1984). However, we wished to
Morphological analysis ~~~~~determine whether the cytolytic effector cells were specific
Morphological analysis ~~~~~for EMT6 target cells only. To determine the target specifi-
Slides were prepared using a Shandon-Elliot cytocentrifuge. city of SAC and PC, a panel of radiolabelled targets was
The slides were air-dried, stained with the Gugol-blue used in a chromium release assay. RIF-1 (a C3H radiation
(Wright-Giemsa) method and differential counts made on induced fibrosarcoma) and line 1 (a BALB/c lung carci-
300-500 cells per slide, noma) were not lysed by SAC and PC effector cells (TableIN SITU CYTOLYTIC HOST CELL POPULATIONS 143
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Figure 1 Comparison of in situ and peripheral cytolytic activity Figure 2 Titration curve of anti-WEHI-164 cytolytic activity.
in the absence of foetal bovine serum. 18h chromium release 18h chromium release assay of SAC (A), PC(L) and spleen cells
assay of SAC (AL), PC (LI) and spleen cells (0) from (0) against WEHI-164 targets.
immunized MTS bearing mice against EMT6 target cells. The
difference between SAC and PC cytolytic activity was significant
at the 95% confidence interval by lytic units analysis. a
50
-
Table I Target lysis specificity of SAC, PC: % specific lysis at 40
various effector to target ratios
SAC PC 30 -
Target 35:1 18:1 9:1 100:1 50:1 25:1
20
-
Experiment I - 18 hour chromium release assay
EMT6 51.1 52.0 38.8 51.5 34.6 24.5
Line-I 0 0 6.2 3.2 0 0 10 ,
P815 39.1 7.1 11.9 28.1 2.8 0 X
Experiment 2 - 18 hour chromium release assay 0
4R b 50:1 25:1 12:1 b
EMT6 24.4 21.6 10.9 23.0 18.9 9.1
D 50
RIF-1 1.5 5.8 6.6 9.8 3.0 3.6
40-
Experiment 3a - 18 hour chromium release assay
EMT6 66.8 54.9 43.5 61.4 53.5 36.0
WEHI-164 17.3 20.0 31.8 35.1 44.4 36.6 30
-
Experiment 3b - 4 hour chromium release assay 20
EMT6 18.8 11.7 6.4 16.3 9.3 3.9
WEHI-164 4.2 4.3 3.1 7.6 4.3 2.5
YAC-1 3.9 3.0 2.5 19.4 16.3 10.5 10
0 O I . . -J..
I). P815 (a DBA/2 mastocytoma) was not killed except at 0.01 0.1 1 10 100
the highest effector to target ratio which may have been Effector/target ratio
influenced by crowded culture conditions. YAC-1, an A/Sn Figure 3 Comparison of cytolytic activity against EMT6 and
lymphoma and NK sensitive line, was not killed by SAC in WEHI-164 in unimmunized spheroid bearing mice. 18h
a 4h chromium release assay although some lysis by PC was chromium release assay of SAC (0) and PC (Cl) vs. EMT6 (A)
present. A 4h assay was used for this target since non- and WEHI-164 (B).
specific lysis by radiolabelled YAC-1 cells was too great at
18 h to yield meaningful data. WEHI-164, an NC and
macrophage but not NK sensitive line (Lattime et al., 1982; It was of interest to determine whether the anti-EMT6 and
1983; Chen et at., 1985; Ortaldo et at., 1986) was killed by anti-WEHI-164 activities were carried out by the same or both the SAC and PC effector cells, different cell populations. To determine the phenotype of the
anti-EMT6 and anti-WEHI-164 effector cells, SAC and PC Characterization. ofte .eiiat-ET)adnnsei were treated with either anti-Thyl or Lyt2 plus complement
(anti-WEHI-164) ytolytic activityprior to the chromium release assay. Antibody plus comple-
The anti-WEHI-164 killing was very high, especially by SAC ment treatment removed the anti-EMT6 activity. Thus
and PC from immunized mice (Figure 2). This killing was Thyl+, Lyt2+ cells were responsible for the anti-EMT6
consistently higher than the anti-EMT6 activity at the lower activity (Figure 4). Antibody plus complement treatment did
effector to target ratios (Figures 1 and 2). not remove anti-WEHI-164 activity; therefore, the anti-
The anti-WEHI-164 but not the anti-EMT6 activity was WEHI-164 effector cells were Thyl-, Lyt2- (Figure 4).
present in spleens from spheroid bearing mice (Figures 1 and These data indicate that the EMT6 and WEHI-164 killers
2). The anti-WEHI effector cell was also demonstrable in are different cell populations.
SAC and PC from unprimed mice while the anti-EMT6 cell To further characterize the cells responsible for killing
was not (Figure 3). EMT6 and WEHI-164, centrifugal elutriation was used to
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Figure 4 Characterization of effector cell responsible for cytolytic activity. 18h chromium release assay of SAC (A, B) and PC
(C, D) against EMT6 (A, C) and WEHI-164 (B, D) targets. Cells were treated with media alone (0), complement alone (El), anti-
Thyl+complement (0) or anti-Lyt2+complement (AL) immediately prior to assay.
Table II Differential counts from elutriated fractions
Fraction % Lymphocytes % Macrophages % Granulocytes % Tumour cells
SAC unsep. 9.2+ O.5a 34.0+7.2 8.8+ 0.5 48.0+6.7
SACL 56.6+ 7.2 14.4+ 1.6 29.0+ 8.8 0
SACM 2.5+ 1.5 70.4+2.9 0.8+ 0.2 26.3+4.2
PC unsep. 57.1 + 4.9 34.7+3.8 8.2+ 1.0 0
PCL 82.5+ 10.0 6.4+ 1.0 11.0+ 11.0 0
PCM 15.7+ 6.3 79.6+6.0 4.7+ 0.4 0
aSEM.
separate SAC and PC subpopulations based on size. It was a concern that the cytolytic activity of SAC
Differential counts of the lymphocyte and macrophage demonstrated in previous studies might be due to foetal
fractions (Table II) indicated a 5 to 20 fold enrichment for bovine serum used to culture cells used in immunization and
one cell type over the other. Anti-EMT6 activity was present in growing MTS. To rule out this possibility, a serum-free,
exclusively in the lymphocyte fraction (Figure 5). Anti- low-protein medium was developed in our laboratory
WEHI-164 activity was present in each fraction but greatest (Taupier et al., 1985; 1986) and used exclusively in these
in the macrophage fraction (Figure 5). experiments. Cytolytic activity was present in infiltrated
EMT6 spheroids from immunized syngeneic BALB/c mice
(Figure 1). This activity was greater than that of peritoneal
Discussion cells (PC) while spleen cells had very little activity.
EMT6 spheroids implanted into immunized syngeneic mice
The multicellular tumour spheroid (MTS) is useful as a become infiltrated by macrophages, granulocytes and
tumour model due to its tumour-like 3-dimensional structure lymphocytes (Lord & Burkhardt, 1984; Table II). Removal
and ease in manipulation (Sutherland et at., 1971; of either Thyl+ or Lyt2+ cells abrogated activity (Figure 4).
MacDonald & Sordat, 1980; Sutherland & Durand, 1984). Thus the cell responsible for anti-EMT6 cytotoxicity was a
This model is especially useful for examining the host cells Thyl+, Lyt2+ cytotoxic T lymphocyte.
which infiltrate tumours. These in situ host immune cells The target cell specificity of SAC and PC was determined
(macrophages, granulocytes, lymphocytes) are often present by utilizing a panel of radiolabelled target cells in the
in different proportions and activity levels than those cells of chromium release assay. The SAC effector cells failed to kill
the periphery (Lord, 1980; Lord & Burkhardt, 1984). The several tumour lines including YAC-l, an NK-sensitive line
MTS model was used to characterize the infiltrating host cell (Table I). This is in agreement with some others who have
population responsible for cytolytic activity against tumour been unable to demonstrate NK cells within tumours
cells and the target lysis specificity. (Eremin et at., 1981; Totterman et at., 1980). It wasIN SITU CYTOLYTIC HOST CELL POPULATIONS 145
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Figure 5 Separation of effector cells by centrifugal elutriation. 18h chromium release assay of SAC (A, B) and PC (C, D) against
EMT6 (A, C) and WEHI-164 (B, D) targets. Cells were separated by centrifugal elutriation into lymphocyte (0) and macrophage
(0) enriched fractions prior to assay.
surprising, however, that the SAC effector cells killed
WEHI-164 to an even greater extent than EMT6 (Figures 1
and 2). These anti-WEHI-164 killers (Thyl-, Lyt2-) were a
different population of cells than the anti-EMT6 effectors
(Thyl+, Lyt2+) (Figure 4). This non-specific activity against
WEHI-164 was also present in host infiltrated tumour
spheroids of line 1, a progressive BALB/c lung carcinoma
(data not shown). The anti-WEHI-164 killers were present in
spleen cells, SAC and PC from unimmunized mice where
anti-EMT6 activity was not evident (Figure 3).
The anti-WEHI-164 activity may have been mediated by
NC cells (Lattime et al., 1982; 1983). Recently it has been
shown that NC activity may be mediated by TNF, a
macrophage derived factor (Ortaldo et al., 1986). Since
macrophages are present in high numbers in situ in the
EMT6 system (Lord & Burkhardt, 1984; Lord & Keng,
1984; Table II) it is possible that this activity was mediated
by a macrophage secreted cytotoxin such as TNF (Kildahl-
Anderson, et al., 1986; Chen et al., 1985; Colotta et al.,
1986; Austgulen et al., 1986). In support of this hypothesis
we found that anti-WEHI-164 activity was greater in
fractions of effector cells enriched for macrophages by
centrifugal elutriation than in fractions enriched for lympho-
cytes (Figure 5). These results indicate that while a lympho-
cyte population is responsible for the specific anti-EMT6
activity, the anti-WEHI-164 activity may be mediated by
macrophages. This activity is present at very low effector to
target ratios and is very high in the in situ host cell
population. Preliminary data suggest that this activity is
carried out by a secreted factor (data not shown).
It is interesting that while anti-EMT6 activity was
exclusively in the lymphocyte fraction, anti-WEHI-164
activity was present to some extent in all fractions although
it was highest in the macrophage fraction. This may be due
to factor production by the small number of contaminating
macrophages over the 18h assay period, since the activity
seen is high even at very low effector to target ratios. It is
also interesting that EMT6 grows progressively as a solid
tumour or tumour spheroids in unimmunized mice (data not
shown). This progressive tumour growth occurs despite the
presence of macrophages capable of cytolytic activity. These
results indicate that EMT6 is insensitive to this macrophage
mediated killing, but does not rule out possible cytostatic
effects.
We have demonstrated direct cytotoxicity of EMT6 by
host cells recovered from MTS in a serum-free system. These
anti-EMT6 effectors cells were Thyl+, Lyt2+ and specific for
EMT6 targets. Thyl-, Lyt2- cells, most likely macrophages,
which mediated WEHI-164 killing were also present in SAC
and PC from unimmunized as well as immunized spheroid
bearing mice. Additional experiments are in progress to
further characterize the WEHI-164 killing and its significance
in anti-tumour immunity.
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